MiniMed’s Nasdaq Debut Underwhelms Amid Market Jitters And Geopolitical Uncertainty

 
• By Shubham Singh
  
The stock opened even lower on debut day at $19.05, placing the company’s market cap at $5.35bn – well below the $7.86bn valuation it had originally targeted. (Shutterstock)

More from Strategy

More from Business